BioSpace News Archive

Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today it has signed a contract with STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, for GMP production of AS1411, Qualigen’s lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials. Preclinical studies a

Clinical update on the detection of Immunoglobulin Light Chain (AL) amyloidosis and differentiation between AL and Transthyretin (ATTR) amyloidosis using AT-01, a novel, potential first-in-class diagnostic for systemic amyloidosis

The new initiative will fuel collaboration and discovery about the biology of Down syndrome and its co-occurring medical conditions

Supplyframe today announced the results of a medical device supply chain study, which indicates a gradual path to recovery for the MedTech industry over the next 18 months.

BeiGene Announces Data on BRUKINSA ® (Zanubrutinib) and Tislelizumab to Be Presented at the 62nd ASH Annual Meeting

ZebiAI is pleased to announce its participation in the 66 million-euro EUbOPEN Consortium, which aims to develop high quality chemical tool compounds for 1,000 proteins (one third of the druggable proteins in the human body). “Enabling and Unlocking biology in the OPEN” (EUbO

ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, invited to a virtual satellite symposium at the EANM Congress 2020 on reviewing “Challenges and Innovative Approaches in the Management of Osteoblastic Metastatic Disease”.

OSAKA, Japan--( BUSINESS WIRE )-- Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced that it will present 22 company-sponsored abstracts at the 62nd American Society of Hematology (ASH) Annual Meeting,

ENDRA Life Sciences Inc. , a pioneer of Thermo Acoustic Enhanced UltraSound today announced that its third quarter financial results will be released on Monday, November 16, 2020 after the U.S. financial markets close.

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc., a provider of wound and skin care products dedicated to improving patient outcomes, announced the launch of BIAKŌS™ Antimicrobial Wound Gel as well as recent viral testing results for BIAKŌS™ Skin and Wound Cleanser.